Skip to main content
. 2024 Nov 8;16(11):484. doi: 10.3390/toxins16110484

Figure 4.

Figure 4

Incidence of urinary tract infection in BoNT-A group and placebo group. (a) Forest plot. (b) Subgroup analysis of 100 U and 200 U doses. (c) Trial sequential analysis plot. UTI, urinary tract infection; BoNT-A, botulinum toxin type A; TSA, trial sequential analysis; CI, confidence interval.